-
Je něco špatně v tomto záznamu ?
European clinical practice guidelines for the definition, diagnosis, and treatment of oligometastatic esophagogastric cancer (OMEC-4)
TE. Kroese, S. Bronzwaer, PSN. van Rossum, SF. Schoppman, PRAJ. Deseyne, E. van Cutsem, K. Haustermans, P. Nafteux, M. Thomas, R. Obermannova, HR. Mortensen, M. Nordsmark, P. Pfeiffer, A. Elme, A. Adenis, G. Piessen, CJ. Bruns, F. Lordick, I....
Jazyk angličtina Země Anglie, Velká Británie
Typ dokumentu časopisecké články, směrnice pro lékařskou praxi, systematický přehled
- MeSH
- delfská metoda MeSH
- konsensus MeSH
- lidé MeSH
- metastázy nádorů MeSH
- nádory jícnu * terapie patologie diagnóza MeSH
- nádory žaludku * terapie patologie diagnóza MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- směrnice pro lékařskou praxi MeSH
- systematický přehled MeSH
- Geografické názvy
- Evropa MeSH
INTRODUCTION: The OligoMetastatic Esophagogastric Cancer (OMEC) project aims to provide clinical practice guidelines for the definition, diagnosis, and treatment of esophagogastric oligometastatic disease (OMD). METHODS: Guidelines were developed according to AGREE II and GRADE principles. Guidelines were based on a systematic review (OMEC-1), clinical case discussions (OMEC-2), and a Delphi consensus study (OMEC-3) by 49 European expert centers for esophagogastric cancer. OMEC identified patients for whom the term OMD is considered or could be considered. Disease-free interval (DFI) was defined as the time between primary tumor treatment and detection of OMD. RESULTS: Moderate to high quality of evidence was found (i.e. 1 randomized and 4 non-randomized phase II trials) resulting in moderate recommendations. OMD is considered in esophagogastric cancer patients with 1 organ with ≤ 3 metastases or 1 involved extra-regional lymph node station. In addition, OMD continues to be considered in patients with OMD without progression in number of metastases after systemic therapy. 18F-FDG PET/CT imaging is recommended for baseline staging and for restaging after systemic therapy when local treatment is considered. For patients with synchronous OMD or metachronous OMD and a DFI ≤ 2 years, recommended treatment consists of systemic therapy followed by restaging to assess suitability for local treatment. For patients with metachronous OMD and DFI > 2 years, upfront local treatment is additionally recommended. DISCUSSION: These multidisciplinary European clinical practice guidelines for the uniform definition, diagnosis and treatment of esophagogastric OMD can be used to standardize inclusion criteria in future clinical trials and to reduce variation in treatment.
Cancer Center Amsterdam Cancer Treatment and Quality of Life Amsterdam the Netherlands
Danish Center of Particle Therapy Aarhus University Medical Center Aarhus University Aarhus Denmark
Department of Medical Oncology Catharina Cancer Institute Eindhoven the Netherlands
Department of Medical Oncology Elisabeth Tweesteden Ziekenhuis Tilburg the Netherlands
Department of Medical Oncology Hospital Universitario de Navarra Pamplona Spain
Department of Medical Oncology IRCM Inserm Université Montpellier ICM Montpellier France
Department of Medical Oncology KU Leuven Leuven University Leuven Belgium
Department of Medical Oncology Odense University Medical Center University of Odense Odense Denmark
Department of Medical Oncology Tallinn University Hospital Tallinn University Tallinn Estonia
Department of Medical Oncology University Hospital Leipzig University of Leipzig Leipzig Germany
Department of Medicine Johannes Gutenberg University Clinic University of Mainz Mainz Germany
Department of Oncology Aarhus University Hospital Aarhus University Aarhus Denmark
Department of Oncology and Radiotherapy Maria Skłodowska Curie Institute Warsaw Poland
Department of Oncology Cambridge University Hospitals Cambridge University Cambridge United Kingdom
Department of Radiation Oncology Amsterdam UMC location VUmc Amsterdam the Netherlands
Department of Radiation Oncology AZ Sint Maarten Mechelen Belgium
Department of Radiation Oncology Catharina Cancer Institute Eindhoven the Netherlands
Department of Radiation Oncology DIMES Alma Mater Studiorum Bologna University Bologna Italy
Department of Radiation Oncology Ghent University Hospital Ghent Belgium
Department of Radiation Oncology IRCCS Azienda Ospedaliero Universitaria di Bologna Bologna Italy
Department of Radiation Oncology KU Leuven Leuven University Leuven Belgium
Department of Radiation Oncology Radboud University Medical Center Nijmegen the Netherlands
Department of Radiation Oncology Radiotherapiegroep Deventer the Netherlands
Department of Radiation Oncology University Hospital Zurich University of Zurich Zurich Switzerland
Department of Surgery Antoni van Leeuwenhoek Netherlands Cancer Institute Amsterdam the Netherlands
Department of Surgery Catharina Cancer Institute Eindhoven the Netherlands
Department of Surgery Fondazione Policlinico Universitario Agostino Gemelli Rome Italy
Department of Surgery Jagiellonian University Medical College Krakow Poland
Department of Surgery KU Leuven Leuven University Leuven Belgium
Department of Surgery Medical School National and Kapodistrian University of Athens Athens Greece
Department of Surgery Medical University of Vienna Vienna University Vienna Austria
Department of Surgery Siena University Hospital University of Siena Siena Italy
Department of Surgery University Hospital Cologne University of Cologne Cologne Germany
Department of Surgery University Hospital Geneva University of Geneva Geneva Switzerland
Department of Surgery University Medical Center Leiden University of Leiden Leiden the Netherlands
Department of Surgery University Medical Center Utrecht Utrecht University Utrecht the Netherlands
Department of Surgical Oncology Medical University of Lublin Lublin Poland
Department of Upper GI and General Surgery PanAsia Surgery Singapore
Trinity St James's Cancer Institute St James Hospital Trinity College Dublin Dublin Ireland
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc24013665
- 003
- CZ-PrNML
- 005
- 20240905134005.0
- 007
- ta
- 008
- 240725e20240416enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.ejca.2024.114062 $2 doi
- 035 __
- $a (PubMed)38678762
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Kroese, Tiuri E $u Department of Radiation Oncology, University Hospital Zurich, University of Zurich, Zurich, Switzerland; Department of Surgery, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands; Department of Radiation Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands
- 245 10
- $a European clinical practice guidelines for the definition, diagnosis, and treatment of oligometastatic esophagogastric cancer (OMEC-4) / $c TE. Kroese, S. Bronzwaer, PSN. van Rossum, SF. Schoppman, PRAJ. Deseyne, E. van Cutsem, K. Haustermans, P. Nafteux, M. Thomas, R. Obermannova, HR. Mortensen, M. Nordsmark, P. Pfeiffer, A. Elme, A. Adenis, G. Piessen, CJ. Bruns, F. Lordick, I. Gockel, M. Moehler, C. Gani, T. Liakakos, JV. Reynolds, AG. Morganti, R. Rosati, C. Castoro, F. Cellini, D. D'Ugo, F. Roviello, M. Bencivenga, G. de Manzoni, MI. van Berge Henegouwen, MCCM. Hulshoff, J. van Dieren, M. Vollebergh, JW. van Sandick, P. Jeene, C. Muijs, M. Slingerland, FEM. Voncken, H. Hartgrink, GJ. Creemers, MJC. van der Sangen, GAP. Nieuwenhuijzen, M. Berbee, M. Verheij, B. Wijnhoven, LV. Beerepoot, NH. Mohammad, S. Mook, JP. Ruurda, P. Kolodziejczyk, WP. Polkowski, L. Wyrwicz, M. Alsina, J. Tabernero, M. Pera, TF. Kanonnikoff, A. Cervantes, M. Nilsson, S. Monig, AD. Wagner, M. Guckenberger, EA. Griffiths, E. Smyth, GB. Hanna, S. Markar, MA. Chaudry, MA. Hawkins, E. Cheong, HWM. van Laarhoven, R. van Hillegersberg, OMEC collaborators
- 520 9_
- $a INTRODUCTION: The OligoMetastatic Esophagogastric Cancer (OMEC) project aims to provide clinical practice guidelines for the definition, diagnosis, and treatment of esophagogastric oligometastatic disease (OMD). METHODS: Guidelines were developed according to AGREE II and GRADE principles. Guidelines were based on a systematic review (OMEC-1), clinical case discussions (OMEC-2), and a Delphi consensus study (OMEC-3) by 49 European expert centers for esophagogastric cancer. OMEC identified patients for whom the term OMD is considered or could be considered. Disease-free interval (DFI) was defined as the time between primary tumor treatment and detection of OMD. RESULTS: Moderate to high quality of evidence was found (i.e. 1 randomized and 4 non-randomized phase II trials) resulting in moderate recommendations. OMD is considered in esophagogastric cancer patients with 1 organ with ≤ 3 metastases or 1 involved extra-regional lymph node station. In addition, OMD continues to be considered in patients with OMD without progression in number of metastases after systemic therapy. 18F-FDG PET/CT imaging is recommended for baseline staging and for restaging after systemic therapy when local treatment is considered. For patients with synchronous OMD or metachronous OMD and a DFI ≤ 2 years, recommended treatment consists of systemic therapy followed by restaging to assess suitability for local treatment. For patients with metachronous OMD and DFI > 2 years, upfront local treatment is additionally recommended. DISCUSSION: These multidisciplinary European clinical practice guidelines for the uniform definition, diagnosis and treatment of esophagogastric OMD can be used to standardize inclusion criteria in future clinical trials and to reduce variation in treatment.
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a nádory jícnu $x terapie $x patologie $x diagnóza $7 D004938
- 650 12
- $a nádory žaludku $x terapie $x patologie $x diagnóza $7 D013274
- 650 _2
- $a konsensus $7 D032921
- 650 _2
- $a metastázy nádorů $7 D009362
- 650 _2
- $a delfská metoda $7 D003697
- 651 _2
- $a Evropa $7 D005060
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a směrnice pro lékařskou praxi $7 D017065
- 655 _2
- $a systematický přehled $7 D000078182
- 700 1_
- $a Bronzwaer, Sebastiaan $u Department of Surgery, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands. Electronic address: r.vanhillegersberg@umcutrecht.nl
- 700 1_
- $a van Rossum, Peter S N $u Department of Radiation Oncology, Amsterdam UMC, location VUmc, Amsterdam, the Netherlands
- 700 1_
- $a Schoppman, Sebastian F $u Department of Surgery, Medical University of Vienna, Vienna University, Vienna, Austria
- 700 1_
- $a Deseyne, Pieter R A J $u Department of Radiation Oncology, Ghent University Hospital, Ghent, Belgium; Department of Radiation Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands
- 700 1_
- $a van Cutsem, Eric $u Department of Medical Oncology, KU Leuven, Leuven University, Leuven, Belgium
- 700 1_
- $a Haustermans, Karin $u Department of Radiation Oncology, KU Leuven, Leuven University, Leuven, Belgium
- 700 1_
- $a Nafteux, Philippe $u Department of Surgery, KU Leuven, Leuven University, Leuven, Belgium
- 700 1_
- $a Thomas, Melissa $u Department of Radiation Oncology, AZ Sint-Maarten, Mechelen, Belgium
- 700 1_
- $a Obermannova, Radka $u Department of Comprehensive Cancer Care, Masaryk Memorial Cancer Institute and Faculty of Medicine, Masaryk, University Brno, Brno, Czech Republic
- 700 1_
- $a Mortensen, Hanna R $u Danish Center of Particle Therapy, Aarhus University Medical Center, Aarhus University, Aarhus, Denmark
- 700 1_
- $a Nordsmark, Marianne $u Department of Oncology, Aarhus University Hospital, Aarhus University, Aarhus, Denmark
- 700 1_
- $a Pfeiffer, Per $u Department of Medical Oncology, Odense University Medical Center, University of Odense, Odense, Denmark
- 700 1_
- $a Elme, Anneli $u Department of Medical Oncology, Tallinn University Hospital, Tallinn University, Tallinn, Estonia
- 700 1_
- $a Adenis, Antoine $u Department of Medical Oncology, IRCM, Inserm, Université Montpellier, ICM, Montpellier, France
- 700 1_
- $a Piessen, Guillaume $u Department of Surgery, Univ. Lille, CNRS, Inserm, CHU Lille, UMR9020-U1277 - CANTHER - Cancer Heterogeneity Plasticity and Resistance to Therapies, F-59000 Lille, France
- 700 1_
- $a Bruns, Christiane J $u Department of Surgery, University Hospital Cologne, University of Cologne, Cologne, Germany
- 700 1_
- $a Lordick, Florian $u Department of Medical Oncology, University Hospital Leipzig, University of Leipzig, Leipzig Germany
- 700 1_
- $a Gockel, Ines $u Department of Visceral, Transplant, Thoracic and Vascular Surgery, University Hospital Leipzig, University of Leipzig, Leipzig, Germany
- 700 1_
- $a Moehler, Markus $u Department of Medicine, Johannes Gutenberg-University Clinic, University of Mainz, Mainz, Germany
- 700 1_
- $a Gani, Cihan $u Department of Radiation Oncology, University Hospital Tubingen, University of Tubingen, Tubingen, Germany
- 700 1_
- $a Liakakos, Theodore $u Department of Surgery, Medical School, National and Kapodistrian University of Athens, Athens, Greece
- 700 1_
- $a Reynolds, John V $u Trinity St James's Cancer Institute, St. James Hospital, Trinity College Dublin, Dublin, Ireland
- 700 1_
- $a Morganti, Alessio G $u Department of Radiation Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy; Department of Radiation Oncology, DIMES, Alma Mater Studiorum - Bologna University, Bologna, Italy
- 700 1_
- $a Rosati, Riccardo $u Department of GI Surgery, IRCCS San Raffaele Scientific Institute, San Raffaele Vita-salute University, Milan, Italy
- 700 1_
- $a Castoro, Carlo $u Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini 4, Pieve Emanuele, Milan 20072, Italy; Upper GI and General Surgery Division, Department of Surgery IRCCS Humanitas Research Hospital, via Manzoni 56, Rozzano, Milan 20089, Italy
- 700 1_
- $a Cellini, Francesco $u Università Cattolica del Sacro Cuore, Dipartimento Universitario Diagnostica per immagini, Radioterapia Oncologica ed Ematologia, Roma, Italy; Fondazione Policlinico Universitario "A. Gemelli" IRCCS, Dipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, Roma, Italy
- 700 1_
- $a D'Ugo, Domenico $u Department of Surgery, Fondazione Policlinico Universitario Agostino Gemelli, Rome, Italy
- 700 1_
- $a Roviello, Franco $u Department of Surgery, Siena University Hospital, University of Siena, Siena, Italy
- 700 1_
- $a Bencivenga, Maria $u General and Upper GI Division, Department of Surgery, Dentistry, Paediatrics and Gynaecology, University of Verona, Verona, Italy
- 700 1_
- $a de Manzoni, Giovanni $u General and Upper GI Division, Department of Surgery, Dentistry, Paediatrics and Gynaecology, University of Verona, Verona, Italy
- 700 1_
- $a van Berge Henegouwen, Mark I $u Department of Surgery, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, the Netherlands
- 700 1_
- $a Hulshoff, Maarten C C M $u Department of Radiation Oncology, Amsterdam UMC, location VUmc, Amsterdam, the Netherlands
- 700 1_
- $a van Dieren, Jolanda $u Department of Gastrointestinal Oncology, Antoni van Leeuwenhoek, Netherlands Cancer Institute, Amsterdam, the Netherlands
- 700 1_
- $a Vollebergh, Marieke $u Department of Medical Oncology, Antoni van Leeuwenhoek, Netherlands Cancer Institute, Amsterdam, the Netherlands
- 700 1_
- $a van Sandick, Johanna W $u Department of Surgery, Antoni van Leeuwenhoek, Netherlands Cancer Institute, Amsterdam, the Netherlands
- 700 1_
- $a Jeene, Paul $u Department of Radiation Oncology, Radiotherapiegroep, Deventer, the Netherlands
- 700 1_
- $a Muijs, Christel $u Department of Radiation Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands
- 700 1_
- $a Slingerland, Marije $u Department of Medical Oncology, University Medical Center Leiden, University of Leiden, Leiden, the Netherlands
- 700 1_
- $a Voncken, Francine E M $u Department of Radiation Oncology, University Medical Center Leiden, University of Leiden, Leiden, the Netherlands
- 700 1_
- $a Hartgrink, Henk $u Department of Surgery, University Medical Center Leiden, University of Leiden, Leiden, the Netherlands
- 700 1_
- $a Creemers, Geert-Jan $u Department of Medical Oncology, Catharina Cancer Institute, Eindhoven, the Netherlands
- 700 1_
- $a van der Sangen, Maurice J C $u Department of Radiation Oncology, Catharina Cancer Institute, Eindhoven, the Netherlands
- 700 1_
- $a Nieuwenhuijzen, Grard A P $u Department of Surgery, Catharina Cancer Institute, Eindhoven, the Netherlands
- 700 1_
- $a Berbee, Maaike $u Department of Radiation Oncology (MAASTRO), GROW School for Oncology and Developmental Biology, Maastricht, the Netherlands
- 700 1_
- $a Verheij, Marcel $u Department of Radiation Oncology, Radboud University Medical Center, Nijmegen, the Netherlands
- 700 1_
- $a Wijnhoven, Bas $u Department of Surgery, Erasmus University Medical Center, University of Rotterdam, Rotterdam, the Netherlands
- 700 1_
- $a Beerepoot, Laurens V $u Department of Medical Oncology, Elisabeth Tweesteden Ziekenhuis Tilburg, the Netherlands
- 700 1_
- $a Mohammad, Nadia Haj $u Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands
- 700 1_
- $a Mook, Stella $u Department of Radiation Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands
- 700 1_
- $a Ruurda, Jelle P $u Department of Surgery, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands
- 700 1_
- $a Kolodziejczyk, Piotr $u Department of Surgery Jagiellonian University Medical College, Krakow, Poland
- 700 1_
- $a Polkowski, Wojciech P $u Department of Surgical Oncology, Medical University of Lublin, Lublin, Poland
- 700 1_
- $a Wyrwicz, Lucjan $u Department of Oncology and Radiotherapy, Maria Skłodowska-Curie Institute, Warsaw, Poland
- 700 1_
- $a Alsina, Maria $u Department of Medical Oncology, Hospital Universitario de Navarra (HUN) and Navarrabiomed - Instituto de Investigación Sanitaria de Navarra (IdiSNA), Pamplona, Spain
- 700 1_
- $a Tabernero, Josep $u Department of Medical Oncology, Vall D'Hebron Hospital Campus and Vall D'Hebron Institute of Oncology (VHIO), CIBERONC, Barcelona, Spain
- 700 1_
- $a Pera, Manuel $u Department of Surgery, Hospital del Mar, Universitat Autònoma de Barcelona, Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain
- 700 1_
- $a Kanonnikoff, Tania F $u Department of Medical Oncology, Hospital Clinico Universitario de Valencia, University of Valencia, Incliva Biomedical Research Institute, Valencia, Spain
- 700 1_
- $a Cervantes, Andrés $u Department of Medical Oncology, Hospital Clinico Universitario de Valencia, University of Valencia, Incliva Biomedical Research Institute, Valencia, Spain
- 700 1_
- $a Nilsson, Magnus $u Division of Surgery and Oncology, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, and Department of Upper Abdominal Diseases, Karolinska University Hospital, Stockholm, Sweden
- 700 1_
- $a Monig, Stefan $u Department of Surgery, University Hospital Geneva, University of Geneva, Geneva, Switzerland
- 700 1_
- $a Wagner, Anna D $u Department of Oncology, Division of Medical Oncology, University Hospital of Lausanne, University of Lausanne, Lausanne, Switzerland
- 700 1_
- $a Guckenberger, Matthias $u Department of Radiation Oncology, University Hospital Zurich, University of Zurich, Zurich, Switzerland
- 700 1_
- $a Griffiths, Ewen A $u Department of Upper Gastrointestinal Surgery, Queen Elizabeth Hospital Birmingham, University Hospital Birmingham, Birmingham, United Kingdom
- 700 1_
- $a Smyth, Elizabeth $u Department of Oncology, Cambridge University Hospitals, Cambridge University, Cambridge, United Kingdom
- 700 1_
- $a Hanna, George B $u Nuffield Department of Surgical Sciences, University of Oxford, United Kingdom, Department of Surgery, Imperial College London, London University, London, United Kingdom
- 700 1_
- $a Markar, Sheraz $u Nuffield Department of Surgical Sciences, University of Oxford, United Kingdom, Department of Surgery, Imperial College London, London University, London, United Kingdom
- 700 1_
- $a Chaudry, M Asif $u Department of GI Cancer & Surgery, The Royal Marsden Hospital & Institute of Cancer Research University of London, London, United Kingdom
- 700 1_
- $a Hawkins, Maria A $u Department of Medical Physics and Biomedical Engineering, University College London, London, United Kingdom
- 700 1_
- $a Cheong, Edward $u Department of Upper GI and General Surgery, PanAsia Surgery, Singapore
- 700 1_
- $a van Laarhoven, Hanneke W M $u Amsterdam UMC location University of Amsterdam, Department of Medical Oncology, Amsterdam, the Netherlands; Cancer Center Amsterdam, Cancer Treatment and Quality of Life, Amsterdam, the Netherlands
- 700 1_
- $a van Hillegersberg, Richard $u Department of Surgery, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands. Electronic address: r.vanhillegersberg@umcutrecht.nl
- 710 2_
- $a OMEC collaborators
- 773 0_
- $w MED00009626 $t European journal of cancer $x 1879-0852 $g Roč. 204 (20240416), s. 114062
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/38678762 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20240725 $b ABA008
- 991 __
- $a 20240905133959 $b ABA008
- 999 __
- $a ok $b bmc $g 2143452 $s 1225531
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2024 $b 204 $c - $d 114062 $e 20240416 $i 1879-0852 $m European journal of cancer $n Eur J Cancer $x MED00009626
- LZP __
- $a Pubmed-20240725
